A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease
Associated ConditionsInflammatory Bowel Disease (IBD)
The purpose of this research study is to measure how effective and how safe BMS-9986164 is in treating study participants with moderate to severe Crohn's Disease (CD). The assessment will be done by measurements on how you are feeling, any side effects or changes to your laboratory tests.
This study is currently enrolling.